Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
Open Access
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (1) , 59-64
- https://doi.org/10.1023/a:1008376728894
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.Journal of Clinical Oncology, 1998
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphomaAnnals of Oncology, 1997
- Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1997
- Fludarabine: A Phase II Trial in Patients with Previously Treated Low-Grade LymphomaAmerican Journal of Clinical Oncology, 1996
- Fludarabine: An active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaAnnals of Oncology, 1993
- Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.Journal of Clinical Oncology, 1992
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992
- Fludarabine phosphate for the treatment of low grade lymphoid malignancyBritish Journal of Cancer, 1991